Lantheus Medical Imaging

Lantheus develops, manufactures and commercializes essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. Its pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography, nuclear imaging and magnetic resonance imaging (MRI) technologies.
The Company's products are routinely used to diagnose coronary artery disease (CAD), congestive heart failure (CHF), stroke, peripheral vascular (PVD) and other diseases. In addition to Lantheus's diversified portfolio of commercialized imaging agents and products, it has a strong development pipeline of internally-discovered next generation, first-in-class imaging agents that use positron emission tomography (PET), MRI technologies focused on enhancing current imaging modalities and fulfilling unmet diagnostic medical imaging needs.

Company Growth (employees)
Billerica, US
Size (employees)
465 (est)
Lantheus Medical Imaging was founded in 1956 and is headquartered in Billerica, US

Lantheus Medical Imaging Office Locations

Lantheus Medical Imaging has offices in Billerica, San Juan and Montréal
Billerica, US (HQ)
331 Treble Cove Rd
Montréal, CA
1111 Boulevard Dr.-Frederik-Philips, Suite 600
San Juan, PR
150 Calle Federico Acosta, Suite 1
Show all (3)

Lantheus Medical Imaging Financials and Metrics

Lantheus Medical Imaging Financials

Lantheus Medical Imaging's revenue was reported to be $301.9 m in FY, 2016

Revenue (Q1, 2017)

81.4 m

Gross profit (Q1, 2017)

39.8 m

Gross profit margin (Q1, 2017), %


Net income (Q1, 2017)

4.1 m

EBIT (Q1, 2017)

11.9 m

Market capitalization (16-Feb-2018)

803.9 m

Cash (31-Mar-2017)

40.9 m
Lantheus Medical Imaging's current market capitalization is $803.9 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


283.7 m301.6 m293.5 m301.9 m

Revenue growth, %


Cost of goods sold

206.3 m176.1 m157.9 m164.1 m

Gross profit

77.4 m125.5 m135.5 m137.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


70.4 m73.3 m75.6 m75.7 m74.8 m73.3 m74.1 m76.5 m78 m73.1 m81.4 m

Cost of goods sold

46.7 m43.3 m44.6 m44 m39.1 m40.6 m40.4 m42.8 m42.2 m39.4 m41.6 m

Gross profit

23.7 m30.1 m31.1 m31.6 m35.8 m32.7 m33.7 m33.7 m35.8 m33.7 m39.8 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


16.7 m17.8 m28.6 m51.2 m

Accounts Receivable

38.9 m41.5 m13.7 m36.8 m


18.3 m15.6 m17.2 m17.6 m

Current Assets

77.3 m79.2 m90.1 m110.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


20.9 m15.1 m14.1 m25.2 m28.8 m22.2 m21.9 m38.9 m54.9 m53.2 m40.9 m

Accounts Receivable

39.9 m


17 m18.5 m16.3 m16.4 m16.2 m15.4 m16.6 m15.5 m14.4 m16.1 m19.8 m

Current Assets

79.4 m82.2 m78.1 m87.4 m88.6 m79 m83.4 m100 m113 m110.5 m106.7 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(61.7 m)(1.2 m)(14.7 m)26.8 m

Depreciation and Amortization

9.3 m9.9 m19.7 m18.3 m

Accounts Receivable

2.6 m(3.6 m)(1.1 m)


1 m(882 k)(3.6 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(15.1 m)(1.3 m)(1.6 m)1.5 m657 k(24.4 m)5.4 m10.3 m7.4 m4.2 m4.1 m

Accounts Receivable

39.9 m


15.4 m16.6 m15.5 m14.4 m16.1 m19.8 m

Accounts Payable

14.2 m10.7 m13 m12.8 m13.6 m17.6 m
USDY, 2017


175 k

Financial Leverage

-2.5 x
Show all financial metrics

Lantheus Medical Imaging Market Value History

Lantheus Medical Imaging's Web-traffic and Trends

Lantheus Medical Imaging Company Life and Culture

You may also be interested in